[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![overnight_stock Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1941151648589434880.png) overnightstocks.com [@overnight_stock](/creator/twitter/overnight_stock) on x XXX followers
Created: 2025-07-21 10:28:48 UTC

$SRPT extends losses pre-market after refusing FDA halt request | via

Sarepta shares fell up to XXX% pre-market after dropping XX% on Friday. The FDA asked Sarepta to voluntarily stop shipments of its Elevidys gene therapy following reports linking it to three patient deaths. Sarepta refused.

- Mizuho downgraded to Neutral due to rising concerns
- BMO sees FDA’s request as more publicity than safety-related
- Sarepta’s refusal makes this a rare case, as companies usually comply with FDA requests


XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947242347055505710/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[losses](/topic/losses)
[$srpt](/topic/$srpt)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/overnight_stock/status/1947242347055505710)